ORIC Pharmaceuticals goes public
South San Francisco and San Diego-based based cancer therapy company ORIC Pharmaceuticals has raised $120 million for its IPO after pricing its 7.5 million shares at $16 per share.
South San Francisco and San Diego-based based cancer therapy company ORIC Pharmaceuticals has raised $120 million for its IPO after pricing its 7.5 million shares at $16 per share.
Copyright PEI Media
Not for publication, email or dissemination